These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
631 related items for PubMed ID: 23880765
1. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. Grozio A, Sociali G, Sturla L, Caffa I, Soncini D, Salis A, Raffaelli N, De Flora A, Nencioni A, Bruzzone S. J Biol Chem; 2013 Sep 06; 288(36):25938-25949. PubMed ID: 23880765 [Abstract] [Full Text] [Related]
2. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model. Sociali G, Raffaghello L, Magnone M, Zamporlini F, Emionite L, Sturla L, Bianchi G, Vigliarolo T, Nahimana A, Nencioni A, Raffaelli N, Bruzzone S. Oncotarget; 2016 Jan 19; 7(3):2968-84. PubMed ID: 26658104 [Abstract] [Full Text] [Related]
3. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms. Zhang XQ, Lu JT, Jiang WX, Lu YB, Wu M, Wei EQ, Zhang WP, Tang C. Neuroscience; 2015 Apr 16; 291():230-40. PubMed ID: 25684751 [Abstract] [Full Text] [Related]
4. FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells. Schuster S, Penke M, Gorski T, Gebhardt R, Weiss TS, Kiess W, Garten A. Biochem Biophys Res Commun; 2015 Mar 06; 458(2):334-40. PubMed ID: 25656579 [Abstract] [Full Text] [Related]
8. Oleate ameliorates palmitate-induced reduction of NAMPT activity and NAD levels in primary human hepatocytes and hepatocarcinoma cells. Penke M, Schuster S, Gorski T, Gebhardt R, Kiess W, Garten A. Lipids Health Dis; 2017 Oct 03; 16(1):191. PubMed ID: 28974242 [Abstract] [Full Text] [Related]
9. Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition. Cea M, Cagnetta A, Fulciniti M, Tai YT, Hideshima T, Chauhan D, Roccaro A, Sacco A, Calimeri T, Cottini F, Jakubikova J, Kong SY, Patrone F, Nencioni A, Gobbi M, Richardson P, Munshi N, Anderson KC. Blood; 2012 Oct 25; 120(17):3519-29. PubMed ID: 22955917 [Abstract] [Full Text] [Related]
10. Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo. Formentini L, Moroni F, Chiarugi A. Biochem Pharmacol; 2009 May 15; 77(10):1612-20. PubMed ID: 19426698 [Abstract] [Full Text] [Related]
11. Pharmacological bypass of NAD+ salvage pathway protects neurons from chemotherapy-induced degeneration. Liu HW, Smith CB, Schmidt MS, Cambronne XA, Cohen MS, Migaud ME, Brenner C, Goodman RH. Proc Natl Acad Sci U S A; 2018 Oct 16; 115(42):10654-10659. PubMed ID: 30257945 [Abstract] [Full Text] [Related]
17. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. Tan B, Young DA, Lu ZH, Wang T, Meier TI, Shepard RL, Roth K, Zhai Y, Huss K, Kuo MS, Gillig J, Parthasarathy S, Burkholder TP, Smith MC, Geeganage S, Zhao G. J Biol Chem; 2013 Feb 01; 288(5):3500-11. PubMed ID: 23239881 [Abstract] [Full Text] [Related]
19. Inhibition of NAMPT markedly enhances plasma-activated medium-induced cell death in human breast cancer MDA-MB-231 cells. Nagaya M, Hara H, Kamiya T, Adachi T. Arch Biochem Biophys; 2019 Nov 15; 676():108155. PubMed ID: 31628926 [Abstract] [Full Text] [Related]